Unity Biotechnology's total assets for Q1 2025 were $30.35M, a decrease of -19.42% from the previous quarter. UBX total liabilities were $30.55M for the fiscal quarter, a -1.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.